Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Feeding | 4 | 2023 | 123 | 1.360 |
Why?
|
| Prostatic Neoplasms | 17 | 2013 | 1068 | 1.130 |
Why?
|
| Nigeria | 42 | 2012 | 92 | 0.850 |
Why?
|
| Prostate-Specific Antigen | 5 | 2007 | 145 | 0.550 |
Why?
|
| Early Detection of Cancer | 4 | 2013 | 428 | 0.440 |
Why?
|
| Fatty Acids | 3 | 2010 | 134 | 0.400 |
Why?
|
| Middle Aged | 39 | 2023 | 11819 | 0.390 |
Why?
|
| Male | 58 | 2023 | 22779 | 0.370 |
Why?
|
| Rural Population | 2 | 2007 | 352 | 0.370 |
Why?
|
| Adult | 44 | 2023 | 13458 | 0.370 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 234 | 0.360 |
Why?
|
| Urban Population | 7 | 2007 | 364 | 0.340 |
Why?
|
| Blood Pressure | 17 | 2004 | 662 | 0.330 |
Why?
|
| Infant, Newborn | 4 | 2023 | 960 | 0.320 |
Why?
|
| Infant | 5 | 2023 | 1143 | 0.320 |
Why?
|
| Humans | 66 | 2023 | 42163 | 0.310 |
Why?
|
| Mothers | 2 | 2023 | 212 | 0.310 |
Why?
|
| Aged | 24 | 2016 | 7982 | 0.300 |
Why?
|
| Detergents | 1 | 2008 | 25 | 0.300 |
Why?
|
| Industry | 1 | 2008 | 30 | 0.290 |
Why?
|
| Anthropometry | 3 | 2007 | 96 | 0.280 |
Why?
|
| Lung Diseases | 1 | 2008 | 62 | 0.280 |
Why?
|
| Occupational Exposure | 1 | 2008 | 89 | 0.280 |
Why?
|
| Polymorphism, Genetic | 6 | 2012 | 200 | 0.260 |
Why?
|
| Adolescent | 16 | 2023 | 5950 | 0.250 |
Why?
|
| Female | 42 | 2023 | 24018 | 0.240 |
Why?
|
| Prostatectomy | 1 | 2006 | 69 | 0.230 |
Why?
|
| Incidence | 7 | 2012 | 1054 | 0.230 |
Why?
|
| Aged, 80 and over | 8 | 2013 | 2803 | 0.220 |
Why?
|
| Body Mass Index | 10 | 2007 | 916 | 0.220 |
Why?
|
| Odds Ratio | 4 | 2010 | 587 | 0.220 |
Why?
|
| Obesity | 7 | 2007 | 1131 | 0.200 |
Why?
|
| Case-Control Studies | 6 | 2012 | 1266 | 0.200 |
Why?
|
| Health Status Disparities | 1 | 2010 | 705 | 0.200 |
Why?
|
| Apolipoproteins | 2 | 2002 | 22 | 0.200 |
Why?
|
| Diabetes Mellitus | 2 | 2013 | 532 | 0.190 |
Why?
|
| Hypertension | 10 | 2006 | 823 | 0.190 |
Why?
|
| Body Height | 3 | 2006 | 53 | 0.180 |
Why?
|
| Albuminuria | 2 | 2001 | 78 | 0.180 |
Why?
|
| Risk Assessment | 3 | 2010 | 845 | 0.170 |
Why?
|
| Diabetes Complications | 1 | 2001 | 99 | 0.170 |
Why?
|
| Diabetic Nephropathies | 1 | 2001 | 74 | 0.170 |
Why?
|
| Quality of Life | 1 | 2006 | 599 | 0.170 |
Why?
|
| Anemia, Sickle Cell | 5 | 1993 | 185 | 0.170 |
Why?
|
| Young Adult | 2 | 2023 | 4936 | 0.170 |
Why?
|
| Pilot Projects | 4 | 2010 | 733 | 0.160 |
Why?
|
| Lipids | 3 | 1999 | 256 | 0.160 |
Why?
|
| Child | 7 | 2023 | 3381 | 0.160 |
Why?
|
| Weight Gain | 1 | 2021 | 138 | 0.160 |
Why?
|
| Risk Factors | 16 | 2012 | 3942 | 0.150 |
Why?
|
| Body Weight | 6 | 1996 | 428 | 0.150 |
Why?
|
| Developing Countries | 3 | 2001 | 112 | 0.140 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2012 | 10 | 0.140 |
Why?
|
| Overweight | 1 | 2021 | 248 | 0.140 |
Why?
|
| United States | 13 | 2016 | 5072 | 0.140 |
Why?
|
| Body Composition | 2 | 1995 | 160 | 0.140 |
Why?
|
| Diet | 3 | 2016 | 810 | 0.140 |
Why?
|
| Pregnancy | 1 | 2023 | 1737 | 0.130 |
Why?
|
| Logistic Models | 3 | 2010 | 1001 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 2 | 2001 | 239 | 0.120 |
Why?
|
| Carotenoids | 1 | 2016 | 74 | 0.120 |
Why?
|
| Alleles | 4 | 2012 | 352 | 0.120 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2012 | 20 | 0.110 |
Why?
|
| Cross-Sectional Studies | 9 | 2016 | 3077 | 0.110 |
Why?
|
| Genetic Variation | 6 | 2002 | 429 | 0.100 |
Why?
|
| Wilms Tumor | 1 | 2013 | 4 | 0.100 |
Why?
|
| Nutrition Disorders | 1 | 1993 | 12 | 0.100 |
Why?
|
| Glomerulonephritis | 1 | 1993 | 14 | 0.100 |
Why?
|
| Nephrotic Syndrome | 1 | 1993 | 11 | 0.100 |
Why?
|
| Educational Status | 4 | 2012 | 335 | 0.100 |
Why?
|
| Mass Screening | 4 | 2006 | 531 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2013 | 959 | 0.100 |
Why?
|
| Health Surveys | 4 | 2010 | 401 | 0.100 |
Why?
|
| Health Services Accessibility | 3 | 2013 | 680 | 0.100 |
Why?
|
| Nutritional Status | 1 | 1993 | 115 | 0.100 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 77 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 727 | 0.090 |
Why?
|
| Activities of Daily Living | 2 | 2004 | 136 | 0.090 |
Why?
|
| Socioeconomic Factors | 10 | 2012 | 1221 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2012 | 30 | 0.090 |
Why?
|
| Analysis of Variance | 5 | 2001 | 574 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 1051 | 0.090 |
Why?
|
| Nutrition Surveys | 1 | 1993 | 263 | 0.090 |
Why?
|
| Time Factors | 2 | 2006 | 1848 | 0.090 |
Why?
|
| Metacarpus | 1 | 1991 | 4 | 0.090 |
Why?
|
| Regression Analysis | 4 | 2001 | 487 | 0.090 |
Why?
|
| Registries | 1 | 2013 | 431 | 0.090 |
Why?
|
| Fingers | 1 | 1991 | 21 | 0.090 |
Why?
|
| Patient Selection | 2 | 2010 | 192 | 0.080 |
Why?
|
| Vital Capacity | 2 | 2008 | 44 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2013 | 1586 | 0.080 |
Why?
|
| Infant Food | 2 | 1980 | 12 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2006 | 438 | 0.080 |
Why?
|
| Cardiovascular Diseases | 5 | 2002 | 729 | 0.080 |
Why?
|
| Poverty | 1 | 2013 | 395 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2010 | 117 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2012 | 471 | 0.080 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2008 | 5 | 0.070 |
Why?
|
| Cholesterol, HDL | 2 | 1999 | 99 | 0.070 |
Why?
|
| Spirometry | 1 | 2008 | 40 | 0.070 |
Why?
|
| Priapism | 1 | 1988 | 2 | 0.070 |
Why?
|
| Respiratory Function Tests | 1 | 2008 | 61 | 0.070 |
Why?
|
| Forced Expiratory Volume | 1 | 2008 | 75 | 0.070 |
Why?
|
| Glycoproteins | 2 | 1999 | 127 | 0.070 |
Why?
|
| Lipoprotein(a) | 2 | 1998 | 6 | 0.070 |
Why?
|
| Leg Ulcer | 1 | 1987 | 8 | 0.070 |
Why?
|
| Prevalence | 3 | 2008 | 1597 | 0.070 |
Why?
|
| Urban Health | 4 | 2010 | 99 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 860 | 0.070 |
Why?
|
| Prostatic Hyperplasia | 2 | 2006 | 32 | 0.070 |
Why?
|
| Reference Values | 3 | 1999 | 207 | 0.070 |
Why?
|
| Physical Examination | 2 | 2005 | 45 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2013 | 1516 | 0.060 |
Why?
|
| Family Planning Services | 1 | 1987 | 34 | 0.060 |
Why?
|
| Motor Activity | 2 | 2007 | 438 | 0.060 |
Why?
|
| Southeastern United States | 3 | 2016 | 58 | 0.060 |
Why?
|
| West Indies | 1 | 2006 | 13 | 0.060 |
Why?
|
| Sex Characteristics | 3 | 1999 | 253 | 0.060 |
Why?
|
| World Health Organization | 1 | 2006 | 36 | 0.060 |
Why?
|
| Family Characteristics | 1 | 1987 | 124 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2006 | 25 | 0.060 |
Why?
|
| Appetite | 1 | 2006 | 21 | 0.060 |
Why?
|
| Urinary Incontinence | 1 | 2006 | 15 | 0.060 |
Why?
|
| Erectile Dysfunction | 1 | 2006 | 39 | 0.060 |
Why?
|
| Fatigue | 1 | 2006 | 97 | 0.060 |
Why?
|
| Sex Factors | 7 | 1995 | 1008 | 0.050 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2004 | 11 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 534 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 43 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 370 | 0.050 |
Why?
|
| Lipoproteins | 2 | 2002 | 68 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2004 | 169 | 0.050 |
Why?
|
| Haplotypes | 1 | 2004 | 197 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 287 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 708 | 0.050 |
Why?
|
| Smoking | 4 | 2011 | 1019 | 0.050 |
Why?
|
| Pain | 1 | 2006 | 283 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2013 | 1729 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2016 | 1574 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2002 | 203 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 1 | 2002 | 31 | 0.050 |
Why?
|
| Caribbean Region | 2 | 2012 | 75 | 0.050 |
Why?
|
| Apolipoprotein A-I | 2 | 1999 | 24 | 0.050 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2002 | 2 | 0.050 |
Why?
|
| Trinucleotide Repeats | 1 | 2001 | 5 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2002 | 99 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 234 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2001 | 85 | 0.040 |
Why?
|
| Social Class | 4 | 1996 | 286 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 1999 | 236 | 0.040 |
Why?
|
| Genotype | 3 | 1999 | 796 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2001 | 85 | 0.040 |
Why?
|
| Feeding Behavior | 2 | 1996 | 461 | 0.040 |
Why?
|
| Electrocardiography | 2 | 1999 | 184 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 1994 | 180 | 0.040 |
Why?
|
| Physicians, Women | 1 | 2000 | 4 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2001 | 77 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2000 | 12 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2001 | 144 | 0.040 |
Why?
|
| Internal Medicine | 1 | 2000 | 32 | 0.040 |
Why?
|
| Sampling Studies | 3 | 1996 | 64 | 0.040 |
Why?
|
| Triglycerides | 2 | 1999 | 146 | 0.040 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1980 | 35 | 0.040 |
Why?
|
| Complement Inactivator Proteins | 1 | 1999 | 1 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1999 | 45 | 0.040 |
Why?
|
| Apolipoproteins C | 1 | 1999 | 3 | 0.040 |
Why?
|
| beta 2-Glycoprotein I | 1 | 1999 | 3 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 1999 | 68 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 1999 | 73 | 0.040 |
Why?
|
| Apolipoproteins A | 1 | 1998 | 1 | 0.040 |
Why?
|
| Kringles | 1 | 1998 | 5 | 0.040 |
Why?
|
| Femur Head | 1 | 1998 | 3 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 1998 | 4 | 0.040 |
Why?
|
| Occupational Health | 1 | 1998 | 30 | 0.040 |
Why?
|
| Fetal Hemoglobin | 2 | 1988 | 13 | 0.040 |
Why?
|
| Body Constitution | 2 | 1997 | 10 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 1999 | 137 | 0.030 |
Why?
|
| Hip Fractures | 1 | 1998 | 29 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 366 | 0.030 |
Why?
|
| Hyperlipoproteinemias | 1 | 1997 | 2 | 0.030 |
Why?
|
| Occupations | 4 | 2001 | 27 | 0.030 |
Why?
|
| Diet, Atherogenic | 1 | 1996 | 7 | 0.030 |
Why?
|
| Exercise | 1 | 2001 | 674 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1996 | 123 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 1994 | 53 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2001 | 744 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 23 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 2013 | 23 | 0.030 |
Why?
|
| Kenya | 1 | 2013 | 56 | 0.030 |
Why?
|
| Sodium | 1 | 1993 | 101 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2013 | 23 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 53 | 0.030 |
Why?
|
| Potassium | 1 | 1993 | 109 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 116 | 0.020 |
Why?
|
| Creatinine | 1 | 1993 | 102 | 0.020 |
Why?
|
| Population Surveillance | 1 | 1994 | 245 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 174 | 0.020 |
Why?
|
| Nutritional Requirements | 1 | 1993 | 33 | 0.020 |
Why?
|
| Nutritive Value | 1 | 1993 | 37 | 0.020 |
Why?
|
| Biopsy | 1 | 1993 | 176 | 0.020 |
Why?
|
| Age Factors | 2 | 1993 | 1139 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 1992 | 53 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 1998 | 1020 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 362 | 0.020 |
Why?
|
| Survival Rate | 1 | 1993 | 353 | 0.020 |
Why?
|
| DNA Primers | 2 | 2004 | 295 | 0.020 |
Why?
|
| Jamaica | 1 | 2012 | 11 | 0.020 |
Why?
|
| SEER Program | 1 | 2012 | 157 | 0.020 |
Why?
|
| Cameroon | 1 | 2012 | 35 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2012 | 65 | 0.020 |
Why?
|
| Hemoglobins | 2 | 1990 | 112 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 234 | 0.020 |
Why?
|
| Genetic Markers | 3 | 2002 | 146 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 118 | 0.020 |
Why?
|
| Heart Rate | 2 | 1995 | 261 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 90 | 0.020 |
Why?
|
| Base Sequence | 2 | 2004 | 997 | 0.020 |
Why?
|
| Radiography | 1 | 1991 | 72 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 168 | 0.020 |
Why?
|
| Students | 2 | 1993 | 617 | 0.020 |
Why?
|
| Hand | 1 | 1991 | 33 | 0.020 |
Why?
|
| Prognosis | 1 | 1993 | 850 | 0.020 |
Why?
|
| Mutation, Missense | 2 | 2002 | 88 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1990 | 1 | 0.020 |
Why?
|
| Random Allocation | 2 | 1987 | 145 | 0.020 |
Why?
|
| Sickle Cell Trait | 1 | 1990 | 19 | 0.020 |
Why?
|
| Tennessee | 1 | 2010 | 88 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 1995 | 641 | 0.020 |
Why?
|
| Income | 1 | 2010 | 160 | 0.020 |
Why?
|
| Hematocrit | 1 | 1988 | 25 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2010 | 180 | 0.020 |
Why?
|
| Community Health Services | 1 | 2010 | 207 | 0.020 |
Why?
|
| Somatotypes | 1 | 1987 | 4 | 0.020 |
Why?
|
| Homozygote | 1 | 1987 | 77 | 0.020 |
Why?
|
| Uric Acid | 1 | 1987 | 29 | 0.020 |
Why?
|
| Selection Bias | 1 | 2006 | 13 | 0.020 |
Why?
|
| Students, Medical | 1 | 1988 | 153 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 2485 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 42 | 0.020 |
Why?
|
| Sex Distribution | 2 | 1997 | 224 | 0.020 |
Why?
|
| Age Distribution | 2 | 1997 | 249 | 0.020 |
Why?
|
| Palpation | 1 | 2005 | 3 | 0.020 |
Why?
|
| Rectum | 1 | 2005 | 27 | 0.010 |
Why?
|
| Alcohol Drinking | 3 | 1997 | 585 | 0.010 |
Why?
|
| Posture | 1 | 2004 | 61 | 0.010 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 65 | 0.010 |
Why?
|
| Life Style | 2 | 1996 | 326 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 106 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 135 | 0.010 |
Why?
|
| Apolipoproteins D | 1 | 2002 | 1 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2002 | 2 | 0.010 |
Why?
|
| Aging | 1 | 1987 | 764 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 92 | 0.010 |
Why?
|
| Minisatellite Repeats | 1 | 2001 | 18 | 0.010 |
Why?
|
| Africa | 1 | 2001 | 81 | 0.010 |
Why?
|
| Recreation | 1 | 2001 | 42 | 0.010 |
Why?
|
| North America | 1 | 2001 | 85 | 0.010 |
Why?
|
| Asia | 1 | 2001 | 99 | 0.010 |
Why?
|
| Private Practice | 1 | 2000 | 2 | 0.010 |
Why?
|
| Group Practice | 1 | 2000 | 8 | 0.010 |
Why?
|
| Pennsylvania | 1 | 2000 | 43 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 548 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 454 | 0.010 |
Why?
|
| Bottle Feeding | 1 | 1980 | 15 | 0.010 |
Why?
|
| Insulin | 1 | 2001 | 255 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2001 | 181 | 0.010 |
Why?
|
| Systole | 1 | 1999 | 67 | 0.010 |
Why?
|
| Diastole | 1 | 1999 | 47 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1979 | 62 | 0.010 |
Why?
|
| Clusterin | 1 | 1999 | 9 | 0.010 |
Why?
|
| Family | 1 | 2000 | 192 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1998 | 29 | 0.010 |
Why?
|
| Femur Neck | 1 | 1998 | 4 | 0.010 |
Why?
|
| Femur | 1 | 1998 | 46 | 0.010 |
Why?
|
| Bone Density | 1 | 1998 | 102 | 0.010 |
Why?
|
| Risk | 1 | 1998 | 289 | 0.010 |
Why?
|
| Attitude to Health | 1 | 1980 | 336 | 0.010 |
Why?
|
| Western World | 1 | 1996 | 2 | 0.010 |
Why?
|
| Government Agencies | 1 | 1996 | 9 | 0.010 |
Why?
|
| Health Education | 1 | 1980 | 358 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 774 | 0.010 |
Why?
|
| Differential Threshold | 1 | 1995 | 5 | 0.010 |
Why?
|
| Africa, Western | 1 | 1995 | 19 | 0.010 |
Why?
|
| Behavior | 1 | 1995 | 34 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1995 | 27 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1995 | 122 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 1998 | 410 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1995 | 281 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1994 | 36 | 0.010 |
Why?
|
| Government | 1 | 1992 | 8 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1994 | 602 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 1992 | 7 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1993 | 638 | 0.010 |
Why?
|
| Biometry | 1 | 1992 | 50 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 1058 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 1992 | 285 | 0.010 |
Why?
|
| Proteinuria | 1 | 1990 | 55 | 0.000 |
Why?
|
| Universities | 1 | 1993 | 539 | 0.000 |
Why?
|
| Cross-Cultural Comparison | 1 | 1988 | 109 | 0.000 |
Why?
|
| Cholesterol | 1 | 1988 | 230 | 0.000 |
Why?
|